Our Solution – LTR Pharma

Our Solution

BRING BACK SPONTANIETY

RAPID ONSET ACTION

PDE5 INHIBITION

SPONTAN®
FASTER IS BETTER

Intranasal delivery technology of safe and effective oral PDE5 inhibitor, Vardenafil HCL
Enhanced trans mucosal absorption
Increased bioavailability and lower drug dose
Faster onset of action
Target clinical indication – erectile dysfunction (ED)
Unique manufacturing process specific to Vardenafil
POC validated
IP Protected

IN DELIVERY
Key Advantages of Intranasal (IN) Delivery

Non-invasive
Bypasses the Liver and 1^st pass metabolism
Large highly vascular surface
improves bioavailability
Provides therapeutic effect at lower dose
Provides faster onset of action
Reduces the risk of systemic exposure and side effects
More convenient for certain patient
groups such as those with dysphagia

Therapeutic effects at lower doses

Learn More

Watch this short animation to learn more about the potential mechanism of action of SPONTAN® – and the science behind its design.

ON DEMAND SOLUTION

LTR Pharma is commercialising a ‘First in Class’ rapid treatment for Erectile Dysfunction (ED) - SPONTAN®

Receive our latest news and investor updates

By entering your email address you are agreeing to our privacy policy.